- Antibodies
- New
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Tag
- Peptides
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Amino Acids
- Tag
- Biological Process >
- Proteins
- RNAi
- FL cDNA Clones
- Cell/Tissues/Lysates
ABLIM3 Antibody (C-term)Peptide Affinity Purified Rabbit Polyclonal Antibody (Pab)
| Country | United States
Ordering Information
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others 
|
|||
|---|---|---|---|---|
| Catalog # | Size | Availability | Price | |
| AP17435b | 0.1 mg 400 ul | In Stock | $ 255.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
| AP17435b-ev20 | Ev20 size 100 ul | In Stock | $ 95.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
- Specification
- Citiations : 0
- Reviews
- Protocols
- Backgrounds
ABLIM3 Antibody (C-term) - Product info | |
| Application | WB
|
| Primary Accession | O94929 |
| Other Accession | Q69ZX8, NP_055760.1 |
| Reactivity | Human |
| Predicted | Mouse |
| Concentration | 0.25 mg/ml |
| Isotype | Rabbit Ig |
| Calculated MW | 77802 Da |
ABLIM3 Antibody (C-term) - Additional info | |
| Gene ID 22885 | |
| Other Names ABLIM3; KIAA0843; Actin-binding LIM protein 3; Actin-binding LIM protein family member 3 | |
| Target/Specificity This ABLIM3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 612-641 amino acids from the C-terminal region of human ABLIM3. | |
| Dilution WB~~1:100~500WB~~1:1000 | |
| Format Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. | |
| Storage Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. | |
| Precautions ABLIM3 Antibody (C-term) is for research use only and not for use in diagnostic or therapeutic procedures. | |
ABLIM3 Antibody (C-term) - Protein Information | |
| Name ABLIM3 | |
| Synonyms KIAA0843 | |
| Function May act as scaffold protein. May stimulate ABRA activity and ABRA-dependent SRF transcriptional activity | |
| Cellular Location Cytoplasm (By similarity). | |
| Tissue Location Expressed predominantly in heart and brain. | |
ABLIM3 Antibody (C-term) - Related products
ABLIM3 Antibody (C-term) - Application data
-
ABLIM3 Antibody (C-term) (Cat. #AP17435b) western blot analysis in CEM cell line lysates (35ug/lane).This demonstrates the ABLIM3 antibody detected the ABLIM3 protein (arrow).
ABLIM3 Antibody (C-term) - Research Areas
Abgent welcomes feedback from its customers.
If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abgent.com.
Thank you for your support.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
The LIM domain is a double zinc finger structure that promotes protein-protein interactions. LIM domain proteins, such as ABLIM3, play roles in embryonic development, cell lineage determination, and cancer (Krupp et al., 2006 [PubMed 16328021]).
REFERENCES
Barrientos, T., et al. J. Biol. Chem. 282(11):8393-8403(2007) Olsen, J.V., et al. Cell 127(3):635-648(2006) Krupp, M., et al. Int. J. Mol. Med. 17(1):129-133(2006) Zheng, B., et al. Biochim. Biophys. Acta 1690(1):1-10(2004) Yamada, S., et al. Oncogene 23(35):5901-5911(2004)
